Eating Disorders Trial, Recruiting NCT05862389 Sponsor: Peking University Condition: Eating Disorders
Back to Eating Disorders

Eating Disorders Trial, Recruiting

NCT05862389
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

For people with Anorexia Nervosa:

  • You have been diagnosed with anorexia nervosa based on standard medical guidelines (DSM-5)
  • You are between 13 and 35 years old (including those ages)
  • Your Body Mass Index (BMI) is between 13 and 17.5
  • You (and your parent or guardian, if you are under 18) are willing to sign a consent form and attend all required appointments and tests
  • You have not taken any psychiatric medications in the past month

For people with Bulimia Nervosa:

  • You have been diagnosed with bulimia nervosa based on standard medical guidelines (DSM-5)
  • You are between 13 and 35 years old (including those ages)
  • You (and your parent or guardian, if you are under 18) are willing to sign a consent form and attend all required appointments and tests
  • You have not taken any psychiatric medications in the past month

Who may not be able to join:

  • You have also been diagnosed with certain other mental health conditions, such as major depression, anxiety, obsessive-compulsive disorder, personality disorder, intellectual disability, or drug or alcohol dependence
  • You have received a brain stimulation treatment called rTMS or electroconvulsive therapy (ECT) in the past six months
  • You currently have serious thoughts of suicide or have recently attempted suicide
  • You are pregnant or breastfeeding
  • You have any medical reason why you cannot have an MRI scan (for example, a metal implant in your body) (confirm with trial site)
  • The trial team considers you unsuitable to participate for any other reason (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Tian-Mei Si, Ph.D, Peking University Sixth Hospital

Phone: 861062723748

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Peking University
Registry
ClinicalTrials.gov
Start date
1 September 2022
Est. completion
1 December 2027

Where this trial is recruiting

🇨🇳 China

Primary endpoints

The change of severity of illness at 8 weeks; The change of eating disorder behaviors and cognition

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov